Moleculent
PrivateLast Round
Series A
Extension
Apr 30, 2026
Total Funding Raised
$46M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Moleculent is a biotechnology company that develops a functional profiling platform to map cell-cell communication directly within clinical tissue.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Moleculent Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Moleculent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 30, 2026 | ||||
| Series A | Jun 11, 2024 |
Key People
Founding team and executive leadership
Moleculent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rubicon Healthcare Partners | Series A Extension |
| ARCH Venture Partners | Series A Extension, Series A |
| Eir Ventures | Series A Extension, Series A |
| ARCH Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 1292% MoM, reaching 5.2K.
- Apr 30, 2026
$20M raised with Rubicon Healthcare Partners leading.
Moleculent Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Moleculent's valuation, stock price, and market status.